Multiple Sclerosis: all 3,525 studies
Page 18 of 36. Open to participants first (669), then studies with results posted, then the rest; newest registration first within each.
- The Feasibility of Frame Running as an Exercise Option for People With Multiple SclerosisCompletedNCT05234879Not applicable
- The Influence of HIIT Versus MCT on Cardiorespiratory Fitness in PPMSStatus unknownNCT05229861Not applicable
- Providing Emotional Support Around the Point of Multiple Sclerosis Diagnosis: PrEliMS 2CompletedNCT05225012Not applicable
- Effectiveness of Cryotherapy on the Fatigue of Patients With Multiple SclerosisCompletedNCT05219201Not applicable
- Evaluation of Relapse Presence in Multiple SclerosisCompletedNCT05218317
- Promoting Aerobic Training in Multiple SclerosisStatus unknownNCT05212805Not applicable
- LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMABActive, not recruitingNCT05210621Phase 3
- Safety of Exposure to Natalizumab During PregnancyCompletedNCT05209815
- Development and Evaluation of the Self-management Module in Patients With Multiple SclerosisStatus unknownNCT05209113Not applicable
- A Study To Determine The Effect Of Ocrelizumab On Leptomeningeal Inflammation In Multiple SclerosisWithdrawnNCT05208840Phase 4
- Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2)-Related Multiple Sclerosis (MS) Vaccination StudyTerminatedNCT05197699
- Expression of PARP-1 in Multiple Sclerosis PatientsCompletedNCT05196425Not applicable
- Reinventing Yourself With Multiple Sclerosis (MS)Status unknownNCT05195320Not applicable
- Validity and Reliability of the Dual-task QuestionnaireCompletedNCT05188937Not applicable
- Investigating the Home-based RCTs of Pilates Exercises and Cognitive Rehabilitation Exercises for Executive Functions and Anxiety in MS.CompletedNCT05185986Not applicable
- Validity and Reliability of Turkish Version Leg Activity MeasureCompletedNCT05182411
- Validity and Reliability of the Modified Four Square Step Test in Multiple Sclerosis PatientsWithdrawnNCT05182398
- Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy SubjectsCompletedNCT05181215Phase 1
- Low-Load Blood Flow Restriction on Patients With Multiple SclerosisCompletedNCT05177952Not applicable
- Adherence to Mediterranean Diet and Cardiovascular Health in Multiple Sclerosis Female Patients: a Case Control StudyCompletedNCT05175378Not applicable
- Sensation, Motion, and Quality of Life on Natalizumab and Off NatalizumabWithdrawnNCT05172466Not applicable
- Safety and Efficacy of Extracorporeal Photopheresis (ECP) in the Treatment of Multiple SclerosisCompletedNCT05168384Phase 1/2
- Impact Program for Multiple SclerosisCompletedNCT05165238Not applicable
- Impact of Fingolimod Adherence on OutcomesCompletedNCT05141669
- Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisActive, not recruitingNCT05134441Phase 3
- Ocrelizumab Access by Socio-Economic StatusCompletedNCT05131984
- CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying TherapyCompletedNCT05131828Phase 2
- A Health Action Process Approach Online Intervention for People With Multiple SclerosisActive, not recruitingNCT05124522Not applicable
- Respiratory Functions in Pediatric-Onset Multiple SclerosisStatus unknownNCT05123924
- Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple SclerosisActive, not recruitingNCT05122559Phase 2
- COVID-19 Vaccine Biomarker Study in Multiple SclerosisCompletedNCT05121662
- A Study to Evaluate White Matter Hyperintensities in MigraineActive, not recruitingNCT05112289Not applicable
- Electrical Stimulations on Pain, Functional Capacity and Quality of Life in Multiple SclerosisCompletedNCT05110586Not applicable
- A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue DamageCompletedNCT05106465
- Robotics for Mobility Rehabilitation in MSCompletedNCT05102682Phase 1
- The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicCompletedNCT05098600
- A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) ElevationActive, not recruitingNCT05090371Phase 4
- Diagnosic and Pronostic Values of Kappa and Lambda Free Light Chains in Central Nervous System Inflammatory DiseasesCompletedNCT05088473
- A Systems Approach to Understanding Disease Processes in Multiple SclerosisCompletedNCT05081700
- COVID-19 Booster Vaccination in Persons With Multiple SclerosisTerminatedNCT05081271Early Phase 1
- Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple SclerosisCompletedNCT05080270Early Phase 1
- Safety and Efficacy of Intrathecal Rituximab in Patients With Multiple SclerosisStatus unknownNCT05078177Phase 1
- Sema 4A as a Marker for Inflammatory Disease in Multiple SclerosisWithdrawnNCT05077956
- Multicenter Observational Study for the Evaluation in Clinical Practice of Urinary Disorders in Multiple SclerosisStatus unknownNCT05075642
- Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and AlemtuzumabStatus unknownNCT05075499Not applicable
- Telerehabilitation-based Upper Extremity Training in People With Multiple SclerosisStatus unknownNCT05073731Not applicable
- Lifestyle Weight Management Program: Interviews and Stakeholder Meetings.Status unknownNCT05070286
- Neuromuscular Electrostimulation in Multiple Sclerosis People With DysphagiaCompletedNCT05063708Not applicable
- COVID-19 Vaccine Response in Treated MS PatientsCompletedNCT05060354
- MS PATHS COVID-19 Questionnaire Data Linkage Sub-StudyCompletedNCT05058729
- Autoimmune Intervention Mastery Course StudyActive, not recruitingNCT05057676Not applicable
- Functions, Physical Activity and Employment for Individuals With MS: A Pilot Feasibility StudyStatus unknownNCT05057338Not applicable
- Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple SclerosisActive, not recruitingNCT05054140Phase 2
- Ultrasound-Guided Percutaneous Neuromodulation in SpasticityStatus unknownNCT05053984Not applicable
- A Long-term Extension of Study GNC-401TerminatedNCT05049161Phase 2
- The Effect of Cigarette Smoke on Sleep Quality and Physical Activity in People With Multiple SclerosisCompletedNCT05046535
- Impact of the Modifications of Environmental Exposures and Health Care Access During COVID-19 Lockdown on Multiple SclerosisCompletedNCT05033782
- Development and Application of Tele-Neuro Rehabilitation SystemStatus unknownNCT05031403Not applicable
- Assessment of Quality of Life and Psychological Problems in Patients With Multiple SclerosisCompletedNCT05029830
- The Effects of Trunk Stabilization and Aerobic Trainings in Multiple SclerosisCompletedNCT05029700Not applicable
- Phase 1b Multiple Ascending Dose Study of Foralumab in Primary and Secondary Progressive MSWithdrawnNCT05029609Phase 1
- Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in SwedenCompletedNCT05029206
- Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving CladribineStatus unknownNCT05019248
- The Role of Social and Territorial Inequalities in the Management and Prognosis of Multiple SclerosisStatus unknownNCT05017038
- Hydroxychloroquine and Indapamide in SPMSStatus unknownNCT05013463Phase 2
- The Reliability of the Nine Hole Peg Test in Patients With Multiple SclerosisActive, not recruitingNCT05012241
- DreaMS - Validation Study 1Active, not recruitingNCT05009160
- Physiological Responses in Experimentally Induced Cognitive Fatigue in People With Multiple Sclerosis (MS)Status unknownNCT05003375
- Thalamic Nuclei Volumes in Multiple SclerosisStatus unknownNCT05002764
- Efficacy of Cognitive Behavioral Therapy on Fatigue, Cognition and Inflammatory Biomarkers in MS PatientsCompletedNCT05002062Not applicable
- Neurophysiological Assessment in Patients With Multiple SclerosisStatus unknownNCT04997343Not applicable
- Symptoms and Treatment Assessment of Ano-Rectal Disorders in Multiple Sclerosis Patients : STAR-QCompletedNCT04996186
- Sensitivity of Motor Assessment in MS - a Prospective Cohort StudyStatus unknownNCT04993274
- A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple SclerosisTerminatedNCT04990219Phase 1
- Territorial Implementation and Evaluation of a Multiple Sclerosis Expert Patient ProgramCompletedNCT04988880Not applicable
- Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male ParticipantsCompletedNCT04982991Phase 1
- Telerehabilitation in Multiple SclerosisStatus unknownNCT04979845Not applicable
- The Validity and Reliability of the Upper Extremity Exercise Testing (UULEX) in Patients With Multiple SclerosisStatus unknownNCT04979819Not applicable
- Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple SclerosisCompletedNCT04979650Phase 2
- Using Patient-Reported Outcomes To Improve the Care of People With Multiple SclerosisCompletedNCT04979546Not applicable
- Strengthening Mental Abilities With Relational Training (SMART) in Multiple Sclerosis (MS): A Feasibility TrialStatus unknownNCT04975685Not applicable
- Functional Disorders of the Musculoskeletal System in People With Multiple SclerosisCompletedNCT04973501Not applicable
- Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled TrialTerminatedNCT04971005Phase 2
- Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable DeviceCompletedNCT04969848
- The Effect of Emotional Freedom Technique on Depression, Anxiety and Distress of Individuals With Multiple SclerosisCompletedNCT04969562Not applicable
- Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple SclerosisCompletedNCT04966338Phase 3
- Analysis of MS Patients Who Have Had Greater Than 60 Infusions of NatalizumabStatus unknownNCT04964700
- An Observational Study to Investigate the Role of B Cells in Multiple SclerosisStatus unknownNCT04964336
- Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMSStatus unknownNCT04963335Not applicable
- A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple SclerosisActive, not recruitingNCT04956744Phase 1
- Technology-assisted Conscientiousness Therapy for People With Multiple SclerosisCompletedNCT04953689Not applicable
- Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy AdultsCompletedNCT04952766Phase 4
- Clinical Isolation Syndrome of Spinal Cord and Multiple SclerosisStatus unknownNCT04952246
- Regular Exercise Improves Physical Capacity and Promotes Neurotrophins in Patients With Multiple SclerosisCompletedNCT04944251Not applicable
- CONNECT Trial of eSupport Online Health-coach Moderated Support Groups for Multiple SclerosisCompletedNCT04943887Not applicable
- Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple SclerosisCompletedNCT04943289Phase 1
- PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy VolunteersCompletedNCT04941781Phase 1
- Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg PenCompletedNCT04940065
- Reading Problems Associated With Central Nervous System (CNS) Pathologies.CompletedNCT04937725
- The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis PatientsCompletedNCT04936555Not applicable